Viacheslav Kaminskiy

Viacheslav Kaminskiy

Auto-generated profile, based on publicly available information

Viacheslav Kaminskiy

Shupyk National Healthcare University of Ukraine, Kyiv

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2019 in Reproductive Endocrinology
Verified
Journal Article
Open access
PDF file
ЮАЮ. Г. Антипкін
Ю. Г. Антипкін
ЮВЮ. П. Вдовиченко
Ю. П. Вдовиченко
АГА. Грациоттін
А. Грациоттін
ВКВ. В. Камінський
В. В. Камінський
ТТТ. Ф. Татарчук
Т. Ф. Татарчук
НРН. М. Рожковська
Н. М. Рожковська
Uterine bleedings and quality of woman's life

9 August 2022 in Reproductive Endocrinology
Verified
Journal Article
Open access
PDF file
VKV.V. Kaminskyi
V.V. Kaminskyi
LVL.I. Vorobei
L.I. Vorobei
OZO.I. Zhdanovych
O.I. Zhdanovych
SKS.M. Korniienko
S.M. Korniienko
TKT.V. Kolomiichenko
T.V. Kolomiichenko
ОFО.р. Fastovets
О.р. Fastovets
Objectives: to determine the clinical and genetic determinants of the severe course of COVID-19 in pregnant women in order to identify a risk group and search for therapeutic targets.Materials and methods. 21 patients (group 1) with a severe course of COVID-19 who required intensive care in the Anesthesiology and Intensive Care Unit (AICU) and 126 pregnant women with moderate severity treated in the Infectious-Obstetrics Unit (IOCU) were examined (group 2). Genomic DNA for molecular genetic analysis of gene variants ACE (I/D, rs 4340), PGR (Alu insertion), ESR1 (A351G, rs 9340799), PON1 (C108T, rs 705379) was isolated from the peripheral blood of patients using a commercial Quick-DNA Miniprep Plus Kit (Zymo Research, USA). Variants of ACE and PGR genes were determined using allele-specific polymerase chain reaction; polymerase chain reaction followed by restriction analysis was used to determine ESR1 and PON1 gene variants.Results. Severe course of COVID-19 is observed in 18.2% of pregnant women, critical condition in 7.5%. A third of AICU patients are over 35 years old. Somatic anamnesis was complicated in 23.8% of patients; thyroid gland pathology (14.3%) and varicose disease (19.0%) prevailed. A significant factor in the severe course of COVID-19 is obesity of the III–IV degree in 28.5% cases. The severe course of the disease was associated with complications of pregnancy (oligohydramnios – 52.4%, ahydramnios – 14.3%, fetal growth retardation syndrome – 33.3%, circulatory disorders – 57.1%, fetal distress – 47.6%, preeclampsia – 14.3%), labor (caesarean section – 57.1%, premature birth – 28.6%), disorders of newborns state (asphyxia – 35.6%). These patients are characterized by anemia (58.7%), thrombocytopenia (23.8%), leukocytosis (33.3%), lymphopenia (90.5%), a shift of the leukocyte formula to the left (an increase of rod-nuclear leukocytes by 85.7%). There were significantly increased levels of transaminases: alanine aminotransferase in 47.6%, aspartate aminotransferase in 76.2%. Prothrombotic changes are indicated by a decrease in prothrombin time and activated partial thromboplastin time in 66.7%, which is confirmed by an increase in D-dimer in 85.7% of patients up to the maximum 15,000 ng/ml in 9.5% of women. An increase in inflammation markers (C-reactive protein and interleukin-6 in all AICU patients, procalcitonin in 66.7%) is a reflection of the destructive effect of inflammatory processes. The genetic determinants of the severe course of COVID-19 in pregnant women can be the ID genotype of the ACE I/D rs4340 polymorphism (81.0%), the T2/T2 PROGINS genotype (19.0%), the ESR1 A351G rs9340799 GG genotype (28.5%).Conclusions. The use of separate clinical, laboratory and genetic indicators in pregnant women with COVID-19 will contribute to the selection of the risk group of a coronavirus severe course and the determination of targets of therapeutic impact.

17 July 2023 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
ASAnastasia Serbeniuk
Anastasia Serbeniuk
VKViacheslav Kaminskiy
Viacheslav Kaminskiy
YKYana Kumpanenko
Yana Kumpanenko
AVAlla Vash‐Margita
Alla Vash‐Margita
IMIryna Malysheva
Iryna Malysheva

29 December 2021 in Reproductive Endocrinology
Verified
Journal Article
Open access
PDF file
VKV.V. Kaminskyi
V.V. Kaminskyi
RTR.O. Tkachenko
R.O. Tkachenko
AKA.V. Kaminskyi
A.V. Kaminskyi
OZO.I. Zhdanovych
O.I. Zhdanovych
LVL.I. Vorobei
L.I. Vorobei
SMS.I. Mudryi
S.I. Mudryi
Research objective: to study the clinical efficacy of the proposed treatment complex in pregnant women with coronavirus disease (COVID-19).Materials and methods. 60 pregnant women with a moderate COVID-19 who were treated at the Kyiv City Center for Reproductive and Perinatal Medicine were examined and selected to assess the effectiveness of the proposed treatment. Pregnant women were divided into 2 clinical groups: the main group (n = 30) were prescribed treatment complex with progestin, the comparison group consisted of 30 pregnant women with COVID-19, who did not differ in age, sex, body mass index and received only standard drug therapy. Given the immunomodulatory effect, micronized progesterone was administered orally 200 mg three times a day immediately after hospitalization for 2 weeks, regardless of gestational age. Clinical manifestations, laboratory and instrumental indicators, duration of oxygen therapy and respiratory support, duration of hospital stay and intensive care were analyzed to assess the treatment complex.Results. Therapeutic complex with progesterone helps to reduce the severity of respiratory disorders in pregnant women with COVID-19, the general condition of pregnant women improves faster and inflammatory changes in the lungs regress. The positive dynamics of pulse oximetry indicators was noted. The frequency of the additional methods of respiratory support and transfer to the intensive care unit were lower, and a more rapid normalization of laboratory parameters was noted. Incidence of gestational complications (threats of pregnancy termination, placental insufficiency, fetal growth retardation and distress, oligohydramnios, premature birth and premature rupture of membranes) was lower against the background of treatment with progesterone, children status was better at birth. The need for oxygen therapy, the length of stay in the intensive care unit and the total length of hospitalization are significantly reduced when progesterone was prescribed for pregnant women with COVID-19.Conclusions. The use of progesterone in pregnant women with coronavirus disease has a stabilizing effect, has no negative side effects which is significantly expands the scope of the proposed therapy in pregnant women at different stages of gestation.

31 May 2024 in Family medicine. European practices
Verified
Journal Article
Open access
PDF file
VKViacheslav Kaminskiy
Viacheslav Kaminskiy
OZOleksii Zhdanovych
Oleksii Zhdanovych
RSRuslan Savchuk
Ruslan Savchuk
TKTetiana Kolomiichenko
Tetiana Kolomiichenko
ВКВ’ячеслав Камінський
В’ячеслав Камінський
ТКТетяна Коломійченко
Тетяна Коломійченко
Considering the importance of perinatal health care, it is necessary to carry out constant monitoring and analysis of the effectiveness of this direction both at the state level and in the section of individual regions. The objective: to assess the effectiveness of perinatal care during the COVID-19 pandemic at the regional level (Ivano-Frankivsk region). Materials and methods. A comparative analysis of the indicators of the effectiveness of perinatal care at the state and regional level (Ivano-Frankivsk region) for 2017–2021 was carried out, which in particular includes 2 years of the COVID-19 pandemic and previous years for the analysis of dynamic trends using statistical data of the Ministry of Health of Ukraine. Results. Despite the fact that perinatal care in Ivano-Frankivsk region for 2017–2021 is at a fairly high level compared to the average indicators in Ukraine, there are certain shortcomings and corresponding reserves for improving its effectiveness. The deterioration of some indicators during the years of the COVID-19 pandemic (2020–2021) in comparison with the last years before the pandemic (2017-2019) was noted: a sharp decrease in the birth rate in 2021 (by 9.76%); in 2020 – an increase in the proportional indicator (per 1,000 births) of early neonatal mortality (from 2.85 to 3.62 of the actual indicator and from 6.47 to 7.82 in real terms), in 2021 – an increase in the proportional indicator of perinatal mortality at weighing less than 1500 g (3 2.27 to 3.44 per 1000 live births), in 2021 a sharp increase in maternal mortality (from 23.98 to 37.4 per 100,000 live births). Conclusions. The obtained indicators reflect both the direct impact of the COVID-19 pandemic on the health of the woman, the fetus and the newborn, as well as the increased load on the perinatal care system and the lack of readiness for crisis challenges. It is necessary to develop a complex of improving the efficiency of perinatal care at all stages (antenatal, intranatal and neonatal) and strengthening the stability of the system in possible crisis situations.

28 May 2024 in Reproductive health of woman
Verified
Journal Article
Open access
PDF file
VKV.V. Kaminskiy
V.V. Kaminskiy
OZO.I. Zhdanovych
O.I. Zhdanovych
RSR.M. Savchuk
R.M. Savchuk
TKT.V. Kolomiichenko
T.V. Kolomiichenko
ОЖО.і. Жданович
О.і. Жданович
It is important to determine mothers’ perceptions of health care services during the pandemic to ensure equity in the provision of such services in the future.The objective: to determine the determinants of pregnant women’s perception of perinatal care services during the COVID-19 pandemic.Materials and methods. An original sociological study was conducted to assess the state of perinatal care during the COVID-19 pandemic using a questionnaire. 110 questionnaires were included in the analysis. Group 1 included 45 female respondents were sick with COVID-19 during pregnancy, group 2 – 65 women were not sick with COVID-19 during pregnancy. All questionnaires were analysed both in the general sample and in the section of COVID-19 during pregnancy.Results. Certain shortcomings in the provision of perinatal care during the COVID-19 pandemic at the ambulatory level were identified. Insufficient vaccination coverage of pregnant women (65.5% of respondents were vaccinated during pregnancy). 87.3% of patients considered insufficient information about vaccination of pregnant women. A negative attitude towards vaccination during pregnancy was expressed by 30.0% of respondents. 65.4% of respondents considered insufficient availability of perinatal care in the conditions of the COVID-19 pandemic. Remote counseling was received by less than half of patients (41.8%), and mainly those who were sick with COVID-19 (62.2%). A negative attitude towards remote counseling was expressed by 49.1% of women. More than half (56.4%) of the respondents considered the provided information about COVID-19, treatment and prevention to be insufficient. Only 9.1% of patients received full psychological support. Half of the patients were not satisfied with the qualifications of the medical staff, and 59.1% were not satisfied with the staff’s attitude. More than half (55.4%) of patients were not satisfied with the care provided at the outpatient stage in general, especially those who did not suffer from COVID-19, which may be due to a shift in the focus of attention on infected pregnant women.Conclusions. The following positions can be recommended to improve perinatal care: expansion of information provision of the population, in particular with the involvement of mass media; conducting explanatory work with patients on prevention, vaccination, treatment, possible complications during pregnancy; provision of remote counseling in possible cases; psychological support of the pregnant woman and her family at all stages of perinatal care.